<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width,initial-scale=1" />
<title>Acute Oncology — GP Quick Reference (UK Primary Care)</title>
<style>
  :root{
    --bg:#0b1220; --card:#121a2b; --muted:#8aa0bf; --text:#e8f0ff;
    --accent:#62d0ff; --amber:#ffbf69; --red:#ff6b6b; --green:#2dd4bf;
    --border:#233049; --shadow:0 10px 30px rgba(0,0,0,.35);
  }
  *{box-sizing:border-box}
  body{margin:0; font:16px/1.45 system-ui, -apple-system, Segoe UI, Roboto, "Helvetica Neue", Arial, "Noto Sans", "Liberation Sans", sans-serif; background:linear-gradient(180deg,#0b1220 0%,#0e1526 100%); color:var(--text);}
  header{position:sticky; top:0; z-index:5; background:rgba(11,18,32,.9); backdrop-filter: blur(6px); border-bottom:1px solid var(--border)}
  .wrap{max-width:1000px; margin:auto; padding:18px}
  h1{font-size:28px; margin:0 0 6px}
  .sub{color:var(--muted); font-size:14px}
  .grid{display:grid; grid-template-columns:repeat(auto-fit,minmax(260px,1fr)); gap:14px}
  .card{background:var(--card); border:1px solid var(--border); border-radius:18px; padding:16px; box-shadow:var(--shadow)}
  .pill{display:inline-block; padding:.2rem .55rem; border-radius:999px; border:1px solid var(--border); color:var(--muted); font-size:12px; margin-right:6px}
  .rag{display:inline-flex; align-items:center; gap:6px}
  .rag b{padding:.2rem .5rem; border-radius:999px; font-size:12px; letter-spacing:.3px}
  .g{background:rgba(45,212,191,.15); color:var(--green); border:1px solid rgba(45,212,191,.35)}
  .a{background:rgba(255,191,105,.15); color:var(--amber); border:1px solid rgba(255,191,105,.35)}
  .r{background:rgba(255,107,107,.15); color:var(--red); border:1px solid rgba(255,107,107,.35)}
  details{border:1px dashed var(--border); border-radius:14px; padding:12px 12px 0; margin:10px 0; background:rgba(255,255,255,.02)}
  details[open]{background:rgba(98,208,255,.04)}
  summary{cursor:pointer; color:var(--accent); font-weight:700; margin:-12px -12px 8px; padding:12px; outline:none}
  code, .mono{font-family:ui-monospace,SFMono-Regular,Menlo,Monaco,"Liberation Mono","DejaVu Sans Mono","Courier New",monospace; font-size:13px}
  .kbd{border:1px solid var(--border); border-bottom-width:3px; padding:.15rem .35rem; border-radius:6px; font-weight:700}
  input[type="search"]{width:100%; padding:12px 14px; border-radius:12px; border:1px solid var(--border); background:#0e1628; color:var(--text)}
  .muted{color:var(--muted)}
  .list{margin:0; padding-left:18px}
  .hl{background:rgba(98,208,255,.25); border-radius:6px; padding:0 3px}
  .footer{color:var(--muted); font-size:12px; text-align:center; margin:24px 0 40px}
  @media print{
    header{position:static; background:#fff; color:#000; border:none}
    body{background:#fff; color:#000}
    .card, details{break-inside:avoid}
  }
</style>
</head>
<body>
<header>
  <div class="wrap">
    <h1>Acute Oncology — GP Quick Reference (UK Primary Care)</h1>
    <div class="sub">Built for rapid consultation in clinic. Use <span class="kbd">/</span> to focus search · <span class="kbd">P</span> to print · <span class="kbd">?</span> for help.</div>
    <div style="margin-top:10px"><input id="q" type="search" placeholder="Search sections (e.g., ‘pneumonitis’, ‘colitis’, ‘neutropenic’, ‘ACP’)…"/></div>
  </div>
</header>

<main class="wrap" id="content">
  <section class="grid">

    <article class="card" data-k="types classification triage overview">
      <h2>1) Classify the AO presentation</h2>
      <ul class="list">
        <li><b>Type 1</b> — New/suspected cancer presenting via emergency pathway.</li>
        <li><b>Type 2</b> — Toxicity/complication of <b>SACT or radiotherapy</b>.</li>
        <li><b>Type 3</b> — Complication of cancer itself (pleural effusion, ascites, MSCC, SVCO).</li>
      </ul>
      <p class="muted">Tip: Decide “toxicity vs tumour” early; both can coexist.</p>
    </article>

    <article class="card" data-k="ukons rag triage toolkit escalation">
      <h2>2) UKONS RAG triage (what to do)</h2>
      <p>Use the UKONS 24-hour triage tool. RAG-rate by symptom <i>severity</i>:</p>
      <p class="rag"><b class="g">GREEN</b> Stop oral SACT if UKONS says so, safety-net, contact AO/CNS same week.</p>
      <p class="rag"><b class="a">AMBER</b> Phone AO helpline now for same-day plan; likely assessment.</p>
      <p class="rag"><b class="r">RED</b> Arrange same-day hospital assessment/ED; alert AO team.</p>
      <details><summary>Common RED examples</summary>
        <ul class="list">
          <li>Fever/unwell post-chemo → possible <b>neutropenic sepsis</b>.</li>
          <li><b>Immunotherapy colitis</b> with ≥6–7 watery stools/day or blood, dehydration.</li>
          <li>New hypoxia/breathlessness → suspected <b>pneumonitis</b>.</li>
          <li>Red flags: <b>MSCC</b>, <b>SVCO</b>, uncontrolled vomiting, severe dehydration, confusion.</li>
        </ul>
      </details>
    </article>

    <article class="card" data-k="know drug coding medication record photo">
      <h2>3) Make the treatment visible</h2>
      <ul class="list">
        <li>Record a problem entry: <span class="mono">On active anti-cancer treatment</span> (add <b>drug + start date</b>).</li>
        <li>Add hospital-only meds to the repeat list (for interaction checks).</li>
        <li>Ask patient to <b>photo the box/clinic letter</b> and keep on their phone.</li>
        <li>Save AO helpline &amp; CNS contact in the care plan.</li>
      </ul>
    </article>

    <article class="card" data-k="toxicities pneumonitis colitis endocrinopathy immunotherapy targeted cdK4/6 adc">
      <h2>4) Toxicity map (recognise fast)</h2>
      <details open><summary>Classic chemotherapy (DNA damage)</summary>
        <ul class="list">
          <li><b>Neutropenic sepsis</b> risk; follow NICE CG151 &amp; sepsis NG51.</li>
          <li>GI toxicity (N/V/D), mucositis; cytopenias.</li>
        </ul>
      </details>
      <details><summary>Targeted/Cell-cycle agents (e.g., <b>CDK4/6 inhibitors</b> like abemaciclib)</summary>
        <ul class="list">
          <li><b>Pneumonitis/ILD</b> (can be severe). New dry cough/dyspnoea → UKONS, stop drug, speak to AO.</li>
          <li>Myelosuppression, diarrhoea common; check interactions.</li>
        </ul>
      </details>
      <details><summary>Antibody–drug conjugates (ADCs)</summary>
        <ul class="list">
          <li><b>Pneumonitis</b> risk (payload can affect lungs). Low threshold to escalate.</li>
        </ul>
      </details>
      <details><summary>Immunotherapy (checkpoint inhibitors)</summary>
        <ul class="list">
          <li><b>irAEs can be delayed</b> months after stopping (pneumonitis, colitis, hepatitis, thyroid/adrenalitis).</li>
          <li>Use UKONS immunotherapy pages; discuss early with AO—steroids may be required.</li>
        </ul>
      </details>
    </article>

    <article class="card" data-k="initial tests observations cxr bloods tfts">
      <h2>5) Initial actions &amp; tests (don’t delay escalation)</h2>
      <ul class="list">
        <li>Identify exact drug/class; check UKONS; <b>call AO helpline</b> early.</li>
        <li>Baseline: <b>FBC, U&amp;Es, LFTs, CRP</b>; consider <b>TFTs</b> if irAE possible.</li>
        <li><b>O<sub>2</sub> sats</b>, <b>CXR</b> for respiratory symptoms.</li>
        <li>Neutropenic sepsis suspected → same-day hospital per NICE; don’t give oral antibiotics unless per local AO protocol.</li>
      </ul>
    </article>

    <article class="card" data-k="safety-net discharge advice who to call">
      <h2>6) Safety-netting script</h2>
      <p>“If fever &gt;38°C, rigors, rapidly worsening breathlessness, bleeding, &gt;6 watery stools/day, or you feel acutely unwell, <b>call the AO helpline now</b> or attend ED. Otherwise, if symptoms persist/worsen over 24–48h, contact us or AO again.”</p>
    </article>

    <article class="card" data-k="acp palliative virtual ward prognosis 70%">
      <h2>7) When to trigger ACP</h2>
      <ul class="list">
        <li>In incurable cancer, an <b>AO/ED admission</b> is a prognostic inflection point.</li>
        <li><b>~70% 12-month mortality</b> after an AO contact → offer **ACP/TEP**, consider palliative referral, anticipatory meds, and virtual ward.</li>
        <li>Document patient priorities; share with community teams.</li>
      </ul>
    </article>

    <article class="card" data-k="clinic checklist template">
      <h2>8) Cancer Care Review — mini checklist</h2>
      <ul class="list">
        <li>Exact <b>drug name(s)</b>, route, schedule; last cycle/date.</li>
        <li>Planned duration/next review; <b>who to call</b> if unwell.</li>
        <li>Screen for toxicities (bowel, breathlessness/cough, rash, fatigue, endocrine).</li>
        <li>Update meds (hospital-only), interactions, contraception/VTE where relevant.</li>
        <li>Holistic needs + <b>ACP readiness</b> (especially after any unplanned admissions).</li>
      </ul>
    </article>

    <article class="card" data-k="references links guidelines">
      <h2>9) References (save locally)</h2>
      <ul class="list">
        <li>UKONS 24-Hour Triage Toolkit &amp; AO Initial Management Guidelines (RAG approach).</li>
        <li>NICE CG151 (Neutropenic sepsis) &amp; NG51 (Sepsis).</li>
        <li>MHRA Drug Safety Update — CDK4/6 inhibitors &amp; ILD/pneumonitis.</li>
        <li>Macmillan/UK AO Society data: ~70% 12-month mortality after AO contact.</li>
      </ul>
      <p class="muted">Store your local AO helpline number here: __________________________</p>
    </article>

  </section>

  <section class="card" data-k="shortcuts help keys print">
    <h2>Keyboard shortcuts</h2>
    <p><span class="kbd">/</span> Focus search · <span class="kbd">P</span> Print · <span class="kbd">E</span> Expand all · <span class="kbd">C</span> Collapse all</p>
  </section>

  <p class="footer">This quick ref supports, not replaces, local AO guidance. If in doubt, phone the AO helpline.</p>
</main>

<script>
  const q = document.getElementById('q');
  const cards = [...document.querySelectorAll('[data-k]')];
  function filter(){
    const t = q.value.toLowerCase().trim();
    cards.forEach(c=>{
      const hit = c.dataset.k.toLowerCase().includes(t) || c.textContent.toLowerCase().includes(t);
      c.style.display = hit ? '' : 'none';
      if(hit) c.querySelectorAll('mark').forEach(m=>m.replaceWith(m.textContent));
      if(t){
        c.innerHTML = c.innerHTML.replace(new RegExp('('+t.replace(/[.*+?^${}()|[\]\\]/g,'\\$&')+')','gi'), '<mark class="hl">$1</mark>');
      }
    });
  }
  q.addEventListener('input', filter);
  window.addEventListener('keydown',e=>{
    if(e.key==='/' && document.activeElement!==q){ e.preventDefault(); q.focus(); }
    if(e.key.toLowerCase()==='p'){ window.print(); }
    if(e.key.toLowerCase()==='e'){ document.querySelectorAll('details').forEach(d=>d.open=true); }
    if(e.key.toLowerCase()==='c'){ document.querySelectorAll('details').forEach(d=>d.open=false); }
    if(e.key==='?' ){ alert('Shortcuts: / focus search · P print · E expand all · C collapse all'); }
  });
</script>
</body>
</html>
